ClinicalTrials.gov
ClinicalTrials.gov Menu

TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00540397
Recruitment Status : Unknown
Verified October 2007 by Shanghai University of Traditional Chinese Medicine.
Recruitment status was:  Recruiting
First Posted : October 8, 2007
Last Update Posted : October 8, 2007
Sponsor:
Information provided by:
Shanghai University of Traditional Chinese Medicine

Brief Summary:
To Elucidate and Confirm the Theory of XuSunShengJi in the Traditional Chinese Medicine Etiological Pathogenesis of Liver Cirrhosis.

Condition or disease Intervention/treatment Phase
Liver Cirrhosis Drug: Fuzhenghuayu Tablet, Huangqi Decoction Granule Not Applicable

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Traditional Chinese Medicine Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cirrhosis
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • With 6 month of chronic liver disease history, and positive serum HBsAg

Exclusion Criteria:

  • Other chronic hepatitis and liver cirrhosis of non-hepatitis B

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00540397


Contacts
Contact: Lie-ming Xu, Professor 00-86-21-51328888 ext 8112 xulieming@shutcm.edu.cn

Locations
China, Shanghai
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Recruiting
Shanghai, Shanghai, China, 200021
Contact: Lie-ming Xu, Professor    0086-21-51328888 ext 8112      
Sponsors and Collaborators
Shanghai University of Traditional Chinese Medicine
Investigators
Principal Investigator: Ping Liu, Professor Shanghai University of Traditional Chinese Medicine

ClinicalTrials.gov Identifier: NCT00540397     History of Changes
Other Study ID Numbers: 2006CB504801
First Posted: October 8, 2007    Key Record Dates
Last Update Posted: October 8, 2007
Last Verified: October 2007

Additional relevant MeSH terms:
Fibrosis
Liver Cirrhosis
Pathologic Processes
Liver Diseases
Digestive System Diseases